Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.3 Immunomodulators | No observations |
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |
| List | Section | Observation |
|---|---|---|
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |
| List | Section | Observation |
|---|---|---|
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |
| List | Section | Observation |
|---|---|---|
| Suriname. NGK-C-011 | 8.2 Cytotoxic Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Haiti. National List of Essential Medicines | 08.02 Cytotoxic and adjuvant drugs | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 8.2 Cytotoxics | No observations |
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 30 TABLETAS |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 41. Antineoplásicos y agentes inmunomoduladores | No observations |
| Suriname. NGK-C-011 | 29.2 Other Special Essential Medicines | No observations |
| Haiti. National List of Essential Medicines | 08.02 Cytotoxic and adjuvant drugs | No observations |